Posted inResearch
FDA draft guidance recommends tissue biopsies only be required in trials if necessary and low risk
Tissue biopsies can be important parts of testing new drugs, and the FDA has now issued a draft guidance with…
Posted inResearch
Clinical trials industry to grapple with new tech, additional uncertainty in 2025: Velocity Clinical Research CEO
Clinical trials in 2025 will be beset by rising costs and uncertain regulations while also benefiting from new technologies and…
Posted inResearch
Clinical research company Javara lays off employees as part of restructuring
Clinical research firm Javara has laid off staff as part of a restructuring, a spokesperson confirmed to Fierce Biotech in…
Posted inResearch
Merck KGaA’s MilliporeSigma absorbs Dutch organoid maker HUB Organoids
Through its U.S. and Canada life science business MilliporeSigma, Merck KGaA is acquiring Dutch company HUB Organoids. The deal is…
Posted inResearch
American Society of Hematology member surveys identify barriers to improving diversity in clinical trials
A pair of assessments conducted by the American Society of Hematology (ASH) have helped identify roadblocks to improving diversity in…
Posted inResearch
Health tech firm Carta Healthcare buys AI company that matches patients to cancer trials
California health tech company Carta Healthcare is upping its artificial intelligence platform with the acquisition of Realyze Intelligence, an oncology-focused…
Posted inResearch
Charles River Laboratories expands incubator to discovery-stage biotechs
Charles River Laboratories is expanding its biotech incubation offering to even earlier in the developmental pipeline. The CRO’s new Charles…
Posted inResearch
AmplifyBio shutters South San Francisco site, lays off preclinical employees in Ohio
AmplifyBio is cutting costs, closing its R&D and characterization services site in South San Francisco and laying off employees in…
Posted inResearch
Franklin Biolabs, the genetic medicines CRO founded by James Wilson, names new chief exec
Franklin Biolabs, the genetic medicines contract research organization that gene therapy expert James Wilson, M.D., Ph.D., spun out of the…
Posted inResearch
CRO and clinical trial markets set for growth by 2030, especially in Asia-Pacific region: reports
The global CRO market is projected to hit almost $63 billion by the end of the decade, growing an average…